Advisors Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,644
Closed -$55K 1430
2023
Q1
$55K Sell
9,644
-326
-3% -$1.97K ﹤0.01% 1295
2022
Q4
$101K Sell
9,970
-22,843
-70% -$429K ﹤0.01% 1245
2022
Q3
$735K Sell
32,813
-746
-2% -$21.6K 0.02% 826
2022
Q2
$832K Sell
33,559
-6,183
-16% -$171K 0.02% 805
2022
Q1
$1.54M Sell
39,742
-3,304
-8% -$128K 0.02% 670
2021
Q4
$2.52M Buy
43,046
+1,678
+4% +$95.1K 0.04% 530
2021
Q3
$2.45M Buy
41,368
+5,902
+17% +$463K 0.04% 532
2021
Q2
$3.08M Buy
35,466
+5,796
+20% +$467K 0.05% 445
2021
Q1
$2.45M Buy
29,670
+12,128
+69% +$1.16M 0.04% 517
2020
Q4
$1.59M Buy
17,542
+11,109
+173% +$690K 0.03% 640
2020
Q3
$257K Buy
6,433
+2,980
+86% +$104K ﹤0.01% 1106
2020
Q2
$118K Buy
+3,453
New +$103K ﹤0.01% 1268

Other funds holding FATE